Senseonics See Few Barriers To Adoption For Their Implantable CGM

GLP-1 inhibitors and an ever-shrinking company ecosystem are not issues for the company, according to its CEO.

paper airplanes
• Source: Shutterstock

More from Diabetic Care

More from Device Area